We are delighted to announce that Statistica Medica Ltd has been awarded the Business All-Star Biostatistical Consultancy Company of the Year 2026 by the All-Ireland Business Foundation (AIBF) — marking the second consecutive year we have received this distinction.
The accreditation, granted following an independent evaluation, recognises companies that demonstrate sustained excellence across three core pillars: Trust, Performance, and Customer Centricity. Achieving the designation for two years in a row reflects the consistency of our work and the standards we hold ourselves to as a biostatistical consultancy company.
This award is possible because of our extraordinary team. Their work ethic and their commitment to every project are outstanding. To deliver at the highest level of quality once is great, to do it consistently, without interruptions and with care is exceptional. This team is truly exceptional.
A Decade of Scientific Excellence
Founded in Dublin in 2012, StatisticaMedica has grown into a trusted biostatistical and strategic consulting partner for pharmaceutical, biotechnology, and medical device organisations. Our work spans the full drug development lifecycle — from early-stage research through to large-scale Phase III clinical trials and Post-Marketing studies — encompassing study design, statistical analysis, data interpretation, and regulatory reporting.
Our team of statisticians and scientists combines deep methodological expertise with practical, evidence-based application, enabling clients to translate complex clinical data into meaningful, regulator-ready insights.
A Reflection of Our Team and Clients
Commenting on the recognition, Gloria Crispino, CEO and Founder of StatisticaMedica, said:
“We’re proud to be recognised as Ireland’s Business All-Star Biostatistical Consultancy Company of the Year 2026 for the second year in a row. This reflects our commitment to scientific rigour, trusted insight, and supporting better decision-making in healthcare and research.”
Looking Ahead
With operations extending across Ireland, the United Kingdom, and continental Europe, StatisticaMedica remains committed to advancing healthcare innovation through high-quality, data-driven research. This renewed accreditation is both a milestone and a motivation — a reminder of the responsibility that comes with being trusted by our clients to deliver work that ultimately supports safer and more effective treatments.
We extend our sincere thanks to our team, our partners, and the AIBF for this continued recognition.
